Martin D. Cheatle

PhD

Associate Professor
Director
Pain and Chemical Dependency Program
Perelman School of Medicine University of Pennsylvania
Center for Study of Addiction
Philadelphia, PA

Disclosures:
Nothing to disclose

Dec 10, 2019 | sleep disorders

Sleep: An Important Ingredient in the Healing Process

Article
Mar 4, 2019

A Q&A with Martin D. Cheatle, PhD

Article
Jan 4, 2019 | suicide

Suicidal Thoughts: A Potentially Deadly Side Effect

Individuals who suffer from chronic pain often present with significant medical and psychiatric comorbidities that can exacerbate the pain experience and contribute to a further erosion of quality of life and disability. Suicide is a serious side effect of chronic pain.

Article
Dec 10, 2018 | abuse

Substance Use Disorder: The Tools of Treatment

Dr. Cheatle reviews some medication and non-medication treatment options for addressing substance use disorder. The message to primary care: a multimodal approach works best, and treatment of the SUD without attention to management of the patient’s underlying pain is the likely route to relapse.

Article
Aug 23, 2018 | chronic pain

Pain, Addiction, and Suicide: Recognition and Response

I think we’ve been so focused on this opioid crisis that we have forgotten that these are very brittle people who have significant psychiatric co-morbidities, including...

Article

Jul 12, 2021

Buprenorphine: A Molecule for All Seasons

Podcast
Apr 16, 2020 | opioid use disorder (OUD)

Back to the Future: Current and Future Opioid Abuse Risk Assessment

Back to the Future:

Podcast
Apr 16, 2020 | opioid use disorder (OUD)

Back to the Future: Current and Future Opioid Abuse Risk Assessment

Current and Future Opioid Abuse Risk Assessment and Mitigation Strategies

Both chronic pain and the harms associated with prescription opioid abuse, including serious adverse events and fatalities, are enormous public health problems. Opioid therapy has been a cornerstone of a multimodal approach to the management of chronic pain. However, the increased rate of opioid prescriptions has been paralleled by the abuse of prescription opioids in the US, escalating more than 113% between 2004 and 2013. Recent clinical guidelines and professional society position papers for opioid prescribing recommend that prior to initiating opioid therapy in selected candidates, providers should screen patients to identify those at risk for developing an opioid use disorder (OUD) and that patients maintained on opioids long term should be routinely monitored for the development of aberrant drug related behaviors suggestive of abuse. (Recorded at PAINWeek 2019)

Podcast
Aug 27, 2019 | comorbidities

Comorbidities in Chronic Pain Patients

Individuals who suffer from chronic pain often present with significant medical and psychiatric comorbidities that can...

Podcast
Aug 27, 2019 | medication

Facilitating Treatment Adherence in Pain Medicine

Surveys of healthcare providers indicate that one of the most distressing features of clinical practice is that of patient...

Podcast

Edit content

Dec 10, 2019 | sleep disorders

Mar 4, 2019

Jan 4, 2019 | suicide

Dec 10, 2018 | abuse

Aug 23, 2018 | chronic pain

Nov 30, 2020 | opioid use disorder (OUD)

May 28, 2020 | risk assessment

Aug 14, 2019 | chronic pain

Jun 12, 2019 | chronic pain

Feb 8, 2018 | abuse

Jul 12, 2021

Apr 16, 2020 | opioid use disorder (OUD)

Apr 16, 2020 | opioid use disorder (OUD)

Aug 27, 2019 | comorbidities

Aug 27, 2019 | medication

Sign-Up